Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Net Income: 2011-2024

Historic Net Income for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $8.6 million.

  • Niagen Bioscience's Net Income rose 143.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 1275.69%. This contributed to the annual value of $8.6 million for FY2024, which is 273.15% up from last year.
  • As of FY2024, Niagen Bioscience's Net Income stood at $8.6 million, which was up 273.15% from -$4.9 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Net Income ranged from a high of $8.6 million in FY2024 and a low of -$27.1 million during FY2021.
  • Its 3-year average for Net Income is -$5.0 million, with a median of -$4.9 million in 2023.
  • In the last 5 years, Niagen Bioscience's Net Income tumbled by 36.15% in 2021 and then spiked by 273.15% in 2024.
  • Over the past 5 years, Niagen Bioscience's Net Income (Yearly) stood at -$19.9 million in 2020, then slumped by 36.15% to -$27.1 million in 2021, then skyrocketed by 31.33% to -$18.6 million in 2022, then surged by 73.49% to -$4.9 million in 2023, then spiked by 273.15% to $8.6 million in 2024.